Latest Conference Articles

There are other mimickers of NTG that should be kept in mind

New products increase the chance of early diagnosis

ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).

New therapies on the horizon offer options for slowing progression

ICYMI: Yvonne Ou, MD, discusses her presentation on "Apps for the visually challenged," during the 2020 Glaucoma 360 annual meeting in San Francisco, California.

Novel technologies range from invasive to non-invasive approaches

Dale Heuer, MD discusses the importance of ophthalmologists identifying and providing more aggressive treatment care for patients with low/high risks of developing glaucoma.

ICYMI: Thomas Samuelson, MD,shares the key highlights from his presentation "Stents, trabs, and tubes: Decision-making in surgical glaucoma."

Dee Stephenson, MD, ABO, discusses the highlights of her presentation "Early Clinical Assessment of Aberration Neutral One-Piece Monofocal Toric IOL with Enhanced Optic Recovery and Alignment ORA" during the 2020 ASCRS virtual meeting.

Reopening practices requires attention to numerous details. As eye care specialists consider re-opening, they have three main challenges that must be overcome to successfully proceed: protect patients, staff, and doctors; project a safe environment; and provide excellent eye care.